This is a Validated Antibody Database (VAD) review about rhesus mac.. CD5, based on 8 published articles (read how Labome selects the articles), using CD5 antibody in all methods. It is aimed to help Labome visitors find the most suited CD5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (UCHT2) |
| BioLegend CD5 antibody (BioLegend, 300617) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi |
mouse monoclonal (UCHT2) |
| BioLegend CD5 antibody (BioLegend, UCHT2) was used in flow cytometry on human samples (fig 1e). Rheumatology (Oxford) (2020) ncbi |
mouse monoclonal (UCHT2) |
| BioLegend CD5 antibody (Biolegend, UCHT2) was used in flow cytometry on human samples (fig 2a). Cell Stem Cell (2019) ncbi |
mouse monoclonal (UCHT2) |
| BioLegend CD5 antibody (Biolegend, 300602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi |
mouse monoclonal (UCHT2) |
| In order to map the lineage of human dendritic cells, BioLegend CD5 antibody (BioLegend, UCHT2) was used in mass cytometry on human samples (fig 1j). Science (2017) ncbi |
mouse monoclonal (UCHT2) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD5 antibody (Biolegend, UCHT2) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
mouse monoclonal (UCHT2) |
| In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend CD5 antibody (biolegend, UCHT2) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi |
mouse monoclonal (UCHT2) |
| BioLegend CD5 antibody (Biolegend, 300622) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments